1.
Eur J Med Chem
; 46(9): 4521-9, 2011 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21820768
RESUMO
Several quinonoid and phenazine compounds were synthesized in moderate to high yields and showed activity against H(37)Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis. The cytotoxity of the compounds were evaluated against human peripheral blood mononuclear cells (PBMC) and these substances emerge as promising antitubercular prototypes.
